Quinapril/Hydrochlorothiazide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Quinapril/Hydrochlorothiazide Tablet (tablet) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Jan 19, 2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- No longer listed by FDA
- Company
- Pfizer Inc.
- Package NDC
- 0071-0223-23
- Dosage Form
- Tablet
- Presentation
- Accuretic, Tablet, 25 mg/20 mg (NDC 0071-0223-23)
- Initial Posting
- Jan 19, 2023
Reason
Discontinuation of the manufacture of the drug